Outcomes of patients with multidrug resistant tuberculosis

A. Bahadir, G. Ortakoylu, G. Ozgul, A. Gencoglu, H. Oztoprak, E. Aynaci, E. Caglar (Istanbul, Turkey)

Source: Annual Congress 2005 - Resistant and MDR tuberculosis
Session: Resistant and MDR tuberculosis
Session type: Thematic Poster Session
Number: 4128
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bahadir, G. Ortakoylu, G. Ozgul, A. Gencoglu, H. Oztoprak, E. Aynaci, E. Caglar (Istanbul, Turkey). Outcomes of patients with multidrug resistant tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 4128

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Outcome of multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Multidrug resistant tuberculosis in non HIV patients
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Treatment outcome of multi-drug resistant tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004


Short course of chemotherapy of multidrug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004

Follow-up and treatment of patients who were diagnosed multidrug resistant tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 11s
Year: 2006

The surgery of multidrug resistant tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 556s
Year: 2003

Evaluation of characteristics and treatment results of patients treated as multidrug resistant tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

Outcome of multi-drug resistant tuberculosis in Belgrade
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Lipid profile in patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 361s
Year: 2002

Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Primary multi-drug resistant tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Efficacy of empiric chemotherapy regimen in patients with multidrug resistant (MDR) tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 656s
Year: 2004

Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003

Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Unit of multidrug resistant tuberculosis - effect of treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 614s
Year: 2002

Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Treatment outcome of multidrug resistant tuberculosis with second line drugs
Source: Eur Respir J 2001; 18: Suppl. 33, 314s
Year: 2001